Related Experiment Video
Updated: May 23, 2025

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Association of Estimated GFR Slope and Heart Failure Progression in Older Adults
Karim Kohansal1, Amir Abdi1, Davood Khalili1
1Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rationale & Objective:
The impact of the estimated glomerular filtration rate (eGFR) slope on the progression of heart failure (HF) remains unclear. This study investigated the association of eGFR slope and the occurrence of incident HF in older adults either at elevated risk for HF or with cardiac abnormalities (structural, hemodynamic, or biomarker) (pre-HF).
Study Design:
Prospective cohort study.
Setting & Participants:
5,362 participants in the Atherosclerosis Risk in Communities at study visit 5 free of HF (at elevated risk [stage A]: n=1,262; with cardiac abnormalities [stage B]: n = 4,100).
Exposure:
eGFR slope, estimated from eGFR measurements between visits 1 and 5 using linear mixed-effects models.
Outcome:
Incident clinical HF based on hospitalization ICD-9/10 codes.
Analytical Approach:
Cause-specific hazard models.
Results:
The mean age of study participants was 75.7 years, 58.4% were female, and the median follow-up was over 6 years. No significant association was found among individuals in stage A. In stage B, each 1mL/min/1.73m2 per year decrease in eGFR slope was associated with a higher risk of HF (HR, 1.39 [95% CI, 1.11-1.73]). Multivariable-adjusted cubic spline analysis indicated that this association was nonlinear among individuals in stage B (P nonlinearity=0.02). Compared with individuals with a moderate-to-high decline in eGFR (-1.87 to-1.25mL/min/1.73m2 per year), individuals in stage B with a steeper eGFR slope (<-1.87mL/min/1.73m2 per year) exhibited an increased risk of incident HF (HR, 1.58 [95% CI, 1.20-2.10]). A steeper eGFR slope in stage B was also significantly associated with HF with preserved ejection fraction (HFpEF) (HR, 1.54 [95% CI, 1.10-2.17]). Among individuals in stage B, there was no detectably elevated risk of incident clinical HF when the eGFR slope was greater than-1.25mL/min/1.73m2 per year.
Limitations:
The eGFR slope may not fully capture the complexity of kidney function decline because it may not account for the fluctuating patterns.
Conclusions:
The eGFR slope may be a valuable measurement to identify individuals at high risk of developing HF, particularly HFpEF.
Plain-Language Summary:
Heart failure (HF) is a prevalent condition in older people, and its occurrence may be affected by kidney function. This study examined the relationship between changes in kidney function assessed by the slope of estimated glomerular filtration rate (eGFR) and the incidence of clinically diagnosed HF. We monitored more than 5,000 older people who were either at elevated risk for HF (stage A) or had cardiac abnormalities of HF (stage B) but had not yet developed clinical HF. Our findings indicated that among individuals in stage B a more rapid decline in kidney function was associated with a greater risk of developing HF, in particular HF with preserved ejection fraction (HFpEF). These findings highlight the potential value of tracking changes in kidney function to identify people at elevated risk of HF.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Heart Failure Drugs: β-Blockers
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...